Ultralife (ULBI) Competitors $8.68 -0.12 (-1.36%) Closing price 07/3/2025 02:35 PM EasternExtended Trading$8.61 -0.07 (-0.79%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ULBI vs. AMPX, BLDP, SLDP, SES, RONI, EAF, FREY, NVX, GAUZ, and ZEOShould you be buying Ultralife stock or one of its competitors? The main competitors of Ultralife include Amprius Technologies (AMPX), Ballard Power Systems (BLDP), Solid Power (SLDP), SES AI (SES), Rice Acquisition Corp. II (RONI), GrafTech International (EAF), FREYR Battery (FREY), NOVONIX (NVX), Gauzy (GAUZ), and Zeo Energy (ZEO). These companies are all part of the "electrical equipment" industry. Ultralife vs. Its Competitors Amprius Technologies Ballard Power Systems Solid Power SES AI Rice Acquisition Corp. II GrafTech International FREYR Battery NOVONIX Gauzy Zeo Energy Amprius Technologies (NYSE:AMPX) and Ultralife (NASDAQ:ULBI) are both small-cap electrical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Do insiders & institutionals hold more shares of AMPX or ULBI? 5.0% of Amprius Technologies shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 12.9% of Amprius Technologies shares are held by company insiders. Comparatively, 40.0% of Ultralife shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor AMPX or ULBI? In the previous week, Amprius Technologies had 3 more articles in the media than Ultralife. MarketBeat recorded 5 mentions for Amprius Technologies and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.94 beat Amprius Technologies' score of 0.45 indicating that Ultralife is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amprius Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ultralife 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer AMPX or ULBI? Amprius Technologies currently has a consensus price target of $9.50, suggesting a potential upside of 103.43%. Ultralife has a consensus price target of $14.00, suggesting a potential upside of 61.29%. Given Amprius Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Amprius Technologies is more favorable than Ultralife.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amprius Technologies 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Ultralife 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AMPX or ULBI more profitable? Ultralife has a net margin of 3.05% compared to Amprius Technologies' net margin of -133.34%. Ultralife's return on equity of 4.61% beat Amprius Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Amprius Technologies-133.34% -67.67% -38.69% Ultralife 3.05%4.61%3.16% Which has more volatility & risk, AMPX or ULBI? Amprius Technologies has a beta of 2.68, suggesting that its stock price is 168% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. Which has stronger earnings and valuation, AMPX or ULBI? Ultralife has higher revenue and earnings than Amprius Technologies. Amprius Technologies is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmprius Technologies$32.52M16.94-$44.67M-$0.41-11.39Ultralife$164.46M0.88$6.31M$0.3227.13 SummaryUltralife beats Amprius Technologies on 10 of the 17 factors compared between the two stocks. Get Ultralife News Delivered to You Automatically Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ULBI vs. The Competition Export to ExcelMetricUltralifeELEC IndustryComputer SectorNASDAQ ExchangeMarket Cap$146.37M$5.25B$27.42B$8.95BDividend YieldN/A2.92%3.13%4.08%P/E Ratio27.1331.6336.2320.04Price / Sales0.882.232,003.24118.51Price / Cash12.4122.5837.8357.47Price / Book1.082.257.265.67Net Income$6.31M$171.53M$762.23M$248.47M7 Day Performance7.16%-0.26%2.64%3.32%1 Month Performance16.04%5.55%5.90%5.20%1 Year Performance-17.02%-1.10%52,290.29%21.35% Ultralife Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ULBIUltralife3.9322 of 5 stars$8.68-1.4%$14.00+61.3%-17.0%$146.37M$164.46M27.13560AMPXAmprius Technologies3.3253 of 5 stars$4.24+4.2%$9.50+124.1%+273.6%$479.96M$24.17M-10.3450News CoverageGap UpBLDPBallard Power Systems1.4526 of 5 stars$1.59+8.9%$2.09+31.4%-23.7%$437.78M$69.73M-1.561,370Gap UpSLDPSolid Power0.6535 of 5 stars$2.19+1.9%$1.50-31.5%+43.0%$385.63M$20.14M-4.29240News CoveragePositive NewsHigh Trading VolumeSESSES AI2.3383 of 5 stars$0.89+0.3%$1.50+68.5%-18.5%$325.55M$2.04M-2.97130RONIRice Acquisition Corp. IIN/A$2.48+4.2%N/A-72.9%$299.47MN/A0.0024High Trading VolumeEAFGrafTech International1.5076 of 5 stars$0.98-7.5%$1.63+65.8%-0.6%$273.60M$538.78M-1.811,072FREYFREYR Battery2.0555 of 5 stars$1.25-3.8%$4.00+220.0%-14.3%$175.61MN/A-1.64210NVXNOVONIX1.1376 of 5 stars$1.01-2.4%N/A-38.0%$164.60M$5.85M0.00N/ANews CoveragePositive NewsGap UpGAUZGauzy3.3413 of 5 stars$8.44-1.7%$13.50+60.0%-31.9%$163.68M$103.53M-2.07N/ANews CoverageGap UpZEOZeo Energy1.2457 of 5 stars$2.90-4.0%N/A+13.4%$148.90M$73.24M-5.09N/AGap Up Related Companies and Tools Related Companies Amprius Technologies Competitors Ballard Power Systems Competitors Solid Power Competitors SES AI Competitors Rice Acquisition Corp. II Competitors GrafTech International Competitors FREYR Battery Competitors NOVONIX Competitors Gauzy Competitors Zeo Energy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ULBI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultralife Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultralife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ULBI Stock Alerts